high-risk COVID-19, high-risk populations, severe outcomes, COVID-19, mortality, hospitalization, respirology, immunology, cardiovascular disease, nephrology, neurology, endocrinology, preventative management, therapeutic management, COVID-19 risk factors
Cannabidiol, CBD, Liver Safety, Drug-Induced Liver Injury, Liver Enzymes, Adverse Drug Reaction